Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease

NCT07148791 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

IgG4 Related Disease
B-cell Mediated Autoimmune Disorders

Interventions

BIOLOGICAL: Anti-BCMA-CD19 CAR-T cells

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]